Fundraising Fox

ExpressCells

Philadelphia, US · Founded 2018 · Delaware corporation

Biotech

Founders & leadership

MH
Matthew HandelExecutive

Board

TA
Tom AndersonBoard director
SB
Sajad BilgramiBoard director
WD
Wendy DiCiccoBoard director

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 2 rounds · 2019–2020

▶$590.5KraisedApr 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom AndersonDirector
  • Matthew HandelExecutive Officer, Director
  • Wendy DiCiccoDirector
  • Sajad BilgramiDirector
Offering amount
$650K
Amount sold
$590.5K
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedSep 2019 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HandelExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Temple gene editing spinout ExpressCells quietly ceases operations, sued by lender - Philadelphia Business Journalbizjournals.com · Mar 2024Creating Better Gene-Edited Cell Lines with the FAST-HDR System - InsideScientificinsidescientific.com · Sep 2022Temple spinout ExpressCells adds new investors to meet 'rapidly growing demand' - Philadelphia Business Journalbizjournals.com · Apr 2021Temple Spinoff Express Cells Secures First Patent for Gene-Editing Technology - Ben Franklin Technology Partnerssep.benfranklin.org · Jan 2021

Frequently asked questions

How much funding has ExpressCells raised?
ExpressCells has disclosed $1.8M raised across 2 rounds.
Where is ExpressCells headquartered?
ExpressCells is headquartered in Philadelphia, US.